SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Summary

This phase II trial is studying how well SB-715992 works in treating patients with recurrent or metastatic head and neck cancer. Drugs used in chemotherapy, such as SB-715992, work in different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start

2005-01

Primary completion

2010-07

Completion

2010-07

Drugs

Indications